Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors

American Journal of Gastroenterology

Volumn 93, Issue 5, 1998, Pages 763-767

  Peghini, Paolo L ^a   Katz, Philip O ^a   Bracy, Nicole A ^a   Castell, Donald O ^a  

^a ALLEGHENY UNIVERSITY HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN EXPERIMENT; MALE; NIGHT SLEEP; PH MEASUREMENT; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH PH;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-ULCER AGENTS; CIRCADIAN RHYTHM; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OMEPRAZOLE; PROTON PUMPS;

EID: 0032081150     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.221_a.x     Document Type: Article

References (27)

1. 1. Cederberg C, Thomson ABR, Mahachai V, et al. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients. Gastroenterology 1992;103:913-8.
2. 2. Sanders SW, Tolman KG, Greski PA, et al. The effects of lansoprazole, a new H+,K+-ATPase inhibitor, on gastric pH and serum gastrin. Aliment Pharmacol Ther 1992;6:359-72.
3. 3. Cederberg C, Röhss, K, Lundborg P, et al. Effect of once daily intravenous and oral omeprazole on 24-hour intragastric acidity in healthy subjects. Scand J Gastroenterol 1993;28:179-84.
4. 4. Dent J, Hetzel DJ, Mackinnon MA, et al. Evaluation of omeprazole in reflux oesophagitis. Scand J Gastroenterol 1989;24(suppl 166):76-82.
5. 5. Mulder CJ, Dekker W, Gerretsen M. Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa. Eur J Gastroenterol Hepatol 1996;8:1101-6.
6. 6. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-12.
7. 7. Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: Effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1996;91:1532-8.
8. 8. Leite LP, Johnston BT, Just RJ, et al. Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996; 91:1527-31.
9. 9. Lind T, Cederberg C, Idström JP, et al. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 1991; 26:620-6.
10. 10. Klinkenberg-Knol EC, Meuwissen SGM. Combined gastric and esophageal 24-hour pH monitoring and esophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther 1990;4:485-95.
11. 11. Chiverton SG, Howden CW, Burget DW, et al. Omeprazole (20 mg) daily given in the morning or evening: A comparison of effects of gastric acidity, and plasma gastrin and omeprazole concentration. Aliment Pharmacol Ther 1992;6:103-11.
12. 12. Pursnani KG, Mohiuddin MA, Geisinger KR, et al. Quantitative evaluation of the role of 'acid-burden' in production of feline esophagitis. Gastroenterology 1996;110:A235.
13. 13. Hendel J, Hendel L, Aggestrup S. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995;9:693-7.
14. 14. Prichard PJ, Yeomans ND, Mihaly GW, et al. Omeprazole: A study of its inhibition of gastric pH and oral pharmaockinetics after morning or evening dosage. Gastroenterology 1985;88:64-9.
15. 15. Fraser AG, Sawyer AM, Hudson M, et al. Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects. Aliment Pharmacol Ther 1996;10:523-7.
16. 16. Hongo M. Ohara S, Hirasawa Y, et al. Effect of lansoprazole on intragastric pH: Comparison between morning and evening dosing. Dig Dis SCi 1992;37:882-90.
17. 17. Yeomans N, Prichard PJ, Jones DB, et al. Morning or evening dosing with low dose omeprazole: Effects on 24-hour gastric acidity profiles in duodenal ulcer patients. Scand J Gastroenterol 1986;21(suppl 118): 152-153.
18. 18. Lind T, Cederberg C, Ekenved G, et al. Effect of omeprazole-a gastric proton pump inhibitor-on pentagastrin stimulated acid secretion in man. Gut 1983;24:270-6.
19. 19. Cederberg C, Andersson T, Skanberg I, et al. Omeprazole: Pharmacokinetics and metabolism in man. Scand J Gastroenterol 1989; 24(suppl 166):33-40.
20. 20. Maton PN. Omeprazole. N Engl J Med 1991;324:965-75.
21. 21. Pilbrant A, Cederberg C. Development of an oral formulation of omeprazole. Scand J Gastroenterol 1985;20(suppl 108):113-20.
22. 22. Moore JG, Englert E. Circadian rhythm of gastric acid secretion in man. Nature 1970;226:1261-2.
23. 23. Wolfe MM, Soll AH. The physiology of gastric acid secretion. N Engl J Med 1988;319:1707-15.
24. 24. Feldman M, Richardson CT. Total 24 hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy. Gastroenterology 1986;90:540-4.
25. 25. Moore JG, Wolfe M. The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man. Digestion 1973;9:97-105.
26. 26. Bell NJV, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992;33:118-24.
27. 27. Katzka DA, Castell DO. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1994;89:989-91.